Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
The European Medicines Agency (EMA) has issued a final guideline on evaluating antibacterial medicines that is globally aligned wi...
The European Commission’s Medical Device Coordination Group (MDCG) has clarified how long legacy devices can remain on the market af...
The Philippine Food and Drug Administration (FDA) is planning to offer an abridged procedure for clinical trial applications by rely...
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
The US Food and Drug Administration published two draft guidances and a revised final guidance that relax its regulatory oversight o...
25 May 2022
07 Jun 2022